IAIM
CLSD

International Assets Investment Management’s Clearside Biomedical CLSD Stock Holding History

International Assets Investment Management’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-847
Closed -$10K – 1015
2024
Q3 		$10K Sell
847
-486
-36% -$8.29K 0.03% 423
2024
Q2 		$26K Sell
1,333
-1,067
-44% -$20.6K ﹤0.01% 1399
2024
Q1 		$56.9K Buy
+2,400
New +$51.7K 0.01% 748

Other funds holding CLSD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

International Assets Investment Management's CLSD Position: Q4 2024 in Review

International Assets Investment Management sold out of Clearside Biomedical (CLSD) in Q4 2024, closing a stake of 847 shares — an estimated $10K sold.

International Assets Investment Management first reported a position in CLSD in Q1 2024 and held it in 3 quarters. The position peaked at $56.9K in Q1 2024. 43 funds tracked by Wall St. Rank hold CLSD as of Q4 2024.

  • International Assets Investment Management reported no remaining Clearside Biomedical position as of Q4 2024 after selling out during the quarter.
  • International Assets Investment Management sold 847 Clearside Biomedical shares in Q4 2024, an estimated $10K.
  • International Assets Investment Management first reported a position in Clearside Biomedical in Q1 2024 and held it in 3 quarters.
  • International Assets Investment Management's Clearside Biomedical position peaked at $56.9K in Q1 2024.
  • 43 funds tracked by Wall St. Rank held Clearside Biomedical as of Q4 2024.

Based on International Assets Investment Management's 13F filing for Q4 2024, filed 8 Jan 2025.